Insmed vs Johnson & Johnson
Insmed (INSM) and Johnson & Johnson (JNJ) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $31B
- Last close
- $141.33
- 12 months
- −29.2%
- Market value
- $651B
- Last close
- $270.47
- 12 months
- +33.2%
At a glance
- The biggest part of Insmed's revenue is ARIKAYCE (72%); at Johnson & Johnson it is Innovative Medicine (64%).
- Insmed earns 75% of its revenue in the United States, Johnson & Johnson 57%.
- By market value, Johnson & Johnson ($651.1B) is about 21 times Insmed ($31.0B).
- Over the last 12 months Insmed's share price moved −29.2% and Johnson & Johnson's +33.2%; against the S&P 500 that is −34.9 points and +27.5 points.
- In their last fiscal years Insmed kept -210.5% of revenue as net income and Johnson & Johnson 28.5%.
- In the last 90 days insiders reported 0 open-market purchases at Insmed and 0 at Johnson & Johnson; members of Congress disclosed 0 trades in Insmed and 5 in Johnson & Johnson.
- Next results: Insmed Feb 17, 2027, Johnson & Johnson Jan 26, 2027.
How each one makes money: Insmed revenue · Johnson & Johnson revenue
Share prices on one chart
Insmed and Johnson & Johnson, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Insmed INSMNASDAQ · Pharmaceutical Preparations | Johnson & Johnson JNJNYSE · Pharmaceuticals | |
|---|---|---|
| Size and profitability | ||
| Market value | $31B | $651B |
| Revenue, last fiscal year | $606M | $94.2B |
| Net income, last fiscal year | −$1.28B | $26.8B |
| Net marginNet income as a share of revenue | -210.5% | 28.5% |
| Free cash flow | −$968M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Johnson & Johnson against
Common questions
How is Insmed different from Johnson & Johnson?
Insmed (INSM) is in Pharmaceutical Preparations on NASDAQ, with $606M of revenue in its last fiscal year and a net margin of -210.5%. Johnson & Johnson (JNJ) is in Pharmaceuticals on NYSE, with $94.2B of revenue in its last fiscal year and a net margin of 28.5%. The biggest part of Insmed's revenue is ARIKAYCE (72%); at Johnson & Johnson it is Innovative Medicine (64%). Insmed earns 75% of its revenue in the United States, Johnson & Johnson 57%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Insmed and Johnson & Johnson compare in size?
Johnson & Johnson has the larger market value: Insmed $31B and Johnson & Johnson $651B, at the last close.
Whose share price rose more over the last 12 months, INSM or JNJ?
Over the last 12 months Insmed moved −29.2% and Johnson & Johnson +33.2%. Past price moves say nothing about the future.
Which has had more insider buying, Insmed or Johnson & Johnson?
Since 2006, Insmed insiders reported 81 open-market purchases against 25 for Johnson & Johnson. These are counts of what was filed, not a view on either stock.
Do members of Congress trade INSM or JNJ?
In the last 12 months, members of Congress disclosed 1 trades in Insmed (INSM) and 24 in Johnson & Johnson (JNJ).
When did insiders last buy INSM and JNJ?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Insmed pageJohnson & Johnson pageRare insider trades this weekAll comparisons
https://oqro.io/compare/insm-vs-jnj







